Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

Nature Medicine

Volumn 2, Issue 6, 1996, Pages 682-685

  Mao, Li ^a   Lee, Jin S ^a   Fan, You H ^a   Ro, Jae Y ^a   Batsakis, John G ^a   Lippman, Scott ^a   Hittelman, Walter ^a   Hong, Waun K ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CARCINOGENESIS; CHROMOSOME 3P; CHROMOSOME 9P; HEAD AND NECK CARCINOMA; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; CLINICAL TRIALS; DNA, SATELLITE; FEMALE; GENE FREQUENCY; GENETIC MARKERS; HETEROZYGOTE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0029929885     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0696-682     Document Type: Article

References (18)

1. Silverman, S., Jr., Gorsky, M. & Lozada, F. Oral leukoplakla and malignant transformation: A follow-up study of 257 patients. Cancer 53, 563-568 (1984).
2. Bánóczy, J. & Csiba, A. Comparative study of the clinical picture and histopathologic structure of oral leukoplakia. Cancer 29, 1230-1234 (1972).
3. Lippman, S.M. et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J. Med. 328, 15-20 (1993).
4. Hong, W.K. et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med. 153, 1501-1505 (1986).
5. Silverman, S., Jr., Gorsky, M. & Lozada, F. Oral leukoplakia and malignant transformation. Cancer 53, 563-568 (1984).
6. Sidransky, D. Molecular genetics of head and neck cancer. Curr. Opin. Oncol. 7, 229-233 (1995).
7. Field, J.K. et al. Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival. Br. J. Cancer 72, 1180-1188 (1995).
8. Nawroz, H. et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54, 1152-1155 (1994).
9. van der Riet, P. et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res. 54, 1156-1158 (1994).
10. Cairns, P. et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nature Genet. 11, 210-212 (1995).
11. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756 (1994).
12. Zhang, S. et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res. 54, 5050-5053 (1994).
13. Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1, 686-692 (1995).
14. Naylor, S.L., Johnson, B.E., Minna, J.D. & Sakaguchi, A.Y. Loss of heterozygosity of chromosome 3p in small-cell lung cancer. Nature 329, 451-454 (1987).
15. Maestro, R. et al. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res. 53, 5775-5779 (1993).
16. Ohta, M. et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587-597 (1996).
17. Kishimoto, Y. et al. Allele- specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J. Natl. Cancer Inst. 87, 1224-1229 (1995).
18. Hung, J. et al. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc. 273, 558-563 (1995).